Trial intelligence / Profile preview

Allopurinol in Hepatic Decompensation

NCT07033533Phase 2Completed

Sponsor
Tanta University
Start
Jun 2022
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of allopurinol in Liver cirrhosis (LC), sponsored by Tanta University. Started Jun 2022; status: completed.

02

Drugs

allopurinol
03

Conditions

Liver cirrhosis (LC)

Beyond the preview

Go deeper on NCT07033533.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07033533.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call